{"organizations": [], "uuid": "c5a322997a42c4682b8ca4d3843ca156bb2ec96c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180427.html", "section_title": "Archive News &amp; Video for Friday, 27 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-united-therapeutics-says-ceo-marti/brief-united-therapeutics-says-ceo-martine-rothblatts-fy-2017-total-compensation-was-37-1-mln-idUSFWN1S40TB", "country": "US", "domain_rank": 408, "title": "BRIEF-United Therapeutics Says CEO Martine Rothblatt's FY 2017 Total Compensation Was $37.1 Mln", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.025, "site_type": "news", "published": "2018-04-27T18:28:00.000+03:00", "replies_count": 0, "uuid": "c5a322997a42c4682b8ca4d3843ca156bb2ec96c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-united-therapeutics-says-ceo-marti/brief-united-therapeutics-says-ceo-martine-rothblatts-fy-2017-total-compensation-was-37-1-mln-idUSFWN1S40TB", "ord_in_thread": 0, "title": "BRIEF-United Therapeutics Says CEO Martine Rothblatt's FY 2017 Total Compensation Was $37.1 Mln", "locations": [], "entities": {"persons": [{"name": "martine rothblatt", "sentiment": "negative"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "united therapeutics corp", "sentiment": "negative"}, {"name": "united therapeutics", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 27 (Reuters) - United Therapeutics Corp:\n* UNITED THERAPEUTICS SAYS CEO MARTINE ROTHBLATTâ€™S FY 2017 TOTAL COMPENSATION WAS $37.1 MILLION WHICH INCLUDED $33.1 MILLION IN OPTION/STAP AWARDS - SEC FILING\n* UNITED THERAPEUTICS SAYS CEO MARTINE ROTHBLATT'S FY 2016 TOTAL COMPENSATION WAS $15.4 MILLION WHICH INCLUDED $12.6 MILLION IN OPTION/STAP AWARDS Source text: [ bit.ly/2I3J07P ] Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://bit.ly/2I3J07P", "https://instagram.com/reuters/"], "published": "2018-04-27T18:28:00.000+03:00", "crawled": "2018-04-28T12:23:09.003+03:00", "highlightTitle": ""}